ABSTRACT
The emergence of highly transmissible SARS-CoV-2 variants has led to surges in cases and the need for global genomic surveillance. While some variants rapidly spread worldwide, other variants only persist nationally. There is a need for more fine-scale analysis to understand transmission dynamics at a country scale. For instance, the Mu variant of interest, also known as lineage B.1.621, was first detected in Colombia and was responsible for a large local wave but only a few sporadic cases elsewhere. To provide a better understanding of the epidemiology of SARS-Cov-2 variants in Colombia, we used 14,049 complete SARS-CoV-2 genomes from the 32 states of Colombia, and performed Bayesian phylodynamic analyses to estimate the time of variants introduction, their respective effective reproductive number, and effective population size, and the impact of disease control measures. We detected a total of 188 SARS-CoV-2 Pango lineages circulating in Colombia since the start of the pandemic. We showed that the effective reproduction number oscillated drastically throughout the first two years of the pandemic, with Mu showing the highest transmissibility (Re and growth rate estimation). Our results reinforce that genomic surveillance programs are essential for countries to make evidence-driven interventions towards the emergence and circulation of novel SARS-CoV-2 variants.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work is supported by the Marsden grant 18-UOA-096 from the Royal Society of New Zealand, Colombia Science Ministry (Minciencias), BPIN 20200000100090. This project was funded by the Universidad del Rosario in the framework of its strategic plan RUTA2025. Thanks to President and the University Council for leading the strategic projects (JR). We also thank the Colombian network for SARS-CoV-2 genomic surveillance led by the National Institute of Health (INS).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Sample collection was led by the Instituto de Investigaciones Biologicas del Tropico at Universidad de Cordoba and the Centro de Investigaciones en Microbiologia y Biotecnologia at Universidad del Rosario, which are part of the official laboratories authorized by Colombias Ministry of Health for testing and genomic surveillance or SARS-CoV-2. Sample collection in Cordoba was approved by the Ethics committee of Universidad de Cordoba IIBT (Acta 0410-2020) in compliance with CDCs guidelines for safe work practices in human diagnostic. Sample collection in Bogota and Cali was approved by Universidad del Rosarios Research Ethics committee (DVO005 1550-CV1400) in compliance with Helsinkis declaration. Informed consent was obtained from all patients.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced in the present study are available online at GISAID
https://github.com/cinthylorein/Colombia-COVID-19-phylodynamics.git
